What is the recommended dexamethasone dose for a child presenting with stridor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dexamethasone Dose for Child with Stridor

For a child presenting with stridor due to croup, administer dexamethasone 0.15 mg/kg as a single oral or intravenous dose, with a maximum dose of 10 mg.

Evidence-Based Dosing

The standard dose of 0.15 mg/kg has been proven equally effective as higher doses (0.6 mg/kg) for treating croup-related stridor 1, 2. This lower dose provides clinical benefit within 30 minutes of administration—much faster than previously thought 1. The evidence demonstrates no additional benefit from using higher doses, making 0.15 mg/kg the optimal choice that balances efficacy with minimizing corticosteroid exposure.

Route of Administration

  • Oral route is preferred when the child can tolerate it
  • Intravenous route is equally effective if oral administration is not feasible 3
  • Both routes show similar clinical outcomes in moderate to severe croup 2

Single vs. Multiple Doses

A single dose is sufficient for most children with croup. The evidence does not support routine use of multiple doses:

  • One dose provides rapid symptom improvement starting at 30 minutes 1
  • Two-dose regimens show no improved outcomes compared to single-dose treatment 4
  • Multiple doses should be reserved for severe cases or those not responding to initial treatment

Context-Specific Considerations

For Croup (Laryngotracheobronchitis)

This is the most common cause of stridor in children presenting acutely. The 0.15 mg/kg dose has strong evidence for reducing admission rates and improving clinical outcomes 5.

For Post-Extubation Stridor

The evidence is less compelling for preventing post-extubation stridor in mechanically ventilated children:

  • Multiple studies show conflicting results 6, 7, 8
  • If used, consider 0.5 mg/kg every 6 hours for 4-6 doses, starting 6-12 hours before planned extubation 8
  • However, routine prophylactic use is not warranted based on current evidence 8
  • The French guidelines suggest considering repeated doses of dexamethasone for high-risk extubations (traumatic intubation, laryngeal edema risk), though benefit in older children remains unproven 9

Important Clinical Caveats

Timing matters: Dexamethasone works faster than traditionally taught. Expect clinical improvement within 30 minutes, not the 4-6 hours previously cited 1. This should encourage earlier treatment and reduce unnecessary admissions.

Age considerations: The 0.15 mg/kg dose applies to children 6 months and older. For younger infants or specific populations (neonates, critically ill), dosing may need adjustment based on pharmacokinetic modeling 10.

Maximum dose: Cap the dose at 10 mg for larger children and adolescents, as higher absolute doses provide no additional benefit 3.

Avoid routine prophylaxis: Do not use dexamethasone routinely for post-extubation stridor prevention in uncomplicated pediatric intensive care cases, as the evidence does not support benefit 8.

References

Research

Role of Intravenous Dexamethasone in Prevention of Postextubation Airway Obstruction in Mechanically Ventilated Children in Pediatric Intensive Care Unit: A Double-blind Randomized Controlled Trial.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2024

Research

Dexamethasone in Prevention of Postextubation Stridor in Ventilated Children: A Randomized, Double-blinded, Placebo-controlled Trial.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.